Zura Bio has launched a Phase 2 trial to evaluate the safety and efficacy of tibulizumab, its experimental dual…
Articles by Andrea Lobo, PhD
Fatigue levels in people with scleroderma, also known as systemic sclerosis or SSc, are tied to several social, demographic,…
The specific self-reactive antibodies (autoantibodies) of people with systemic sclerosis (SSc) overlap syndrome — a condition in which SSc…
The Scleroderma Research Foundation (SRF) has announced the star-studded lineup for its annual Cool Comedy, Hot Cuisine fundraising…
Patients with systemic sclerosis (SSc) who have a stem cell transplant see normalized gene activity related to immune function…
CONQUEST, a platform clinical trial launched by the Scleroderma Research Foundation (SRF), is now enrolling people with interstitial lung…
Having scleroderma increases the risk of developing diseases affecting blood vessels of the brain or heart, known as cerebrovascular…
The U.S. Food and Drug Administration (FDA) has granted orphan drug status to BLR-200, a medication that BLR Bio…
People with scleroderma who feel more socially isolated are more likely to report being dissatisfied with life, but this…
Certa Therapeutics’ FT011, an investigational oral therapy for systemic sclerosis (SSc), has been granted fast track designation by the…